Vigabatrin in pediatric patients with refractory epilepsy

Turkish Journal of Pediatrics

Volumn 48, Issue 1, 2006, Pages 25-30

  Turanli, Güzide ^a   Çelebi, Asli ^a   Yalnizoǧlu, Dilek ^a   Topçu, Meral ^a   Anlar, Banu ^a   Topaloǧlu, Haluk ^a   Aysun, Sabiha ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Efficacy; Intractable epilepsy; Side effect; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INCREASED APPETITE; INFANT; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MENTAL DEFICIENCY; MONOTHERAPY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ONSET AGE; PHYSICAL EXAMINATION; REVIEW; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; EPILEPSIES, PARTIAL; EPILEPSY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; VIGABATRIN;

EID: 33644804221     PISSN: 00414301     EISSN: 00414301     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Bélanger S, Coulombe G, Carmant L. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes. Epilepsia 1998; 39: 878-883.
2. Lewis H, Wallace SJ. Vigabatrin. Dev Med Child Neurol 2001; 43: 833-835.
3. Gale K. GABA and epilepsy: basic concepts from preclinic research. Epilepsia 1992; 33 (Suppl): S3-12.
4. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996; 47: 1567-1571.
5. http://www.mentalhealth.com/drug/p30-s07.html.
6. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-399.
7. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993; 43: S21-S23.
8. Gibbs JM, Appleton RE, Rosenbloom L. Vigabatrin in intractable childhood epilepsy: a retrospective study. Pediatr Neurol 1992; 8: 338-340.
9. Prasad AN, Penney S, Buckley DJ. The role of vigabatrin in childhood seizure disorders: results from a clinical audit. Epilepsia 2001; 42: 54-61.
10. Gram L, Klosterskov P, Dam M. Gamma-vinyl GABA: a double blind placebo controlled trial in partial epilepsy. Ann Neurol 1985; 17:262-266.
11. Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ. Vigabatrin in drug resistant partial epilepsy: a 5-year follow-up study. Neurology 1991; 41: 562-565.
12. Tartara A, Mani R, Galimberti CA, et al. Six years follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992; 86: 247-251.
13. Rimmer EM, Richens A. Double blind study of gammavinyl GABA in patients with refractory epilepsy. Lancet 1984; 1: 1989-1990.
14. Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003; 60 (Suppl): S2-S12.
15. Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995; 4: 45-48.
16. Nabbout R, Melki I, Gerbaka B, Dulac O, Akatcherian C. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001; 42: 1580-1583.
17. Elterman RD, Shields WD, Mansfield KA, Nakagawa J. US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001; 57: 1416-1421.
18. Lortie A, Chiron C, Mumford J, Dulac O. The potential for increased seizure frequency, relapse and appearance of new seizure types with vigabatrin. Neurology 1993; 43 (Suppl): 24-27.
19. Manuchehri K, Goodman S, Siviter L, Nightingale S. A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 2000; 84: 499-505.
20. Gross-Tsur V, Banin E, Shahar E, Shalev RS, Lahat E. Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurology 2000; 48: 60-64.
21. Lawden MC, Eke T, Degg C, Harding GF, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999; 67: 716-722.
22. Hardus P, Verduin WM, Postma G, Stilma JS, Berendschot TT, van Veelen CW. Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin. Br J Ophthalmol 2000; 84: 788-790.
23. Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999; 106: 1792-1798.
24. Schmidt T, Scmitz B, Jokiel B, et al. Constriction of the visual field in epilepsy patients taking vigabatrin and other antiepileptic drugs: a longitudinal study. Epilepsia 1999; 40 (Suppl): 256.
25. Vigabatrin Pediatric Advisory Group. Guideline for prescribing vigabatrin in children has been revised. Br Med J 2000; 320: 1404-1405.
26. McDonagh J, Stephen LJ, Dolan FM, et al. Peripheral retinal dysfunction in patients taking vigabatrin. Neurology 2003; 61: 1690-1694.